Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 15/20 | 0.81 |
| ▸ | CYP1A1 | P04798 | 15/20 | 0.81 |
| ▸ | CYP1B1 | Q16678 | 15/20 | 0.81 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.66 |
| ▸ | MAPT | P10636 | 2/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.66 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.66 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.66 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.66 |
| ▸ | CYP4B1 | P13584 | 1/20 | 0.66 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.66 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.66 |
| ▸ | CYP2A7 | P20853 | 1/20 | 0.66 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12090696 | 1.00 | CYP1A2 (0.81) | CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1 | |
| SCHEMBL3172823 | 1.00 | CYP1A2 (0.81) | CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1 | |
| SCHEMBL25706432 | 0.90 | CYP1A2 (1.00) | CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1 | |
| SCHEMBL15932970 | 0.89 | CYP1A2 (0.75) | CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1 | |
| SCHEMBL26924044 | 0.86 | CYP1A2 (0.84) | CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1 | |
| SCHEMBL265496 | 0.84 | CYP1A1 (0.70) | CYP1A2CYP1A1CYP1B1NFE2L2CYP3A4 | |
| SCHEMBL14224730 | 0.84 | CYP1A1 (0.70) | CYP1A2CYP1A1CYP1B1NFE2L2CYP3A4 | |
| SCHEMBL30474601 | 0.84 | CYP1A1 (0.70) | CYP1A2CYP1A1CYP1B1NFE2L2CYP3A4 | |
| SCHEMBL7871043 | 0.84 | CYP1A1 (0.70) | CYP1A2CYP1A1CYP1B1NFE2L2CYP3A4 | |
| SCHEMBL14528012 | 0.84 | CYP1A2 (0.58) | CYP1A2CYP1A1CYP1B1NFE2L2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101717692-B | Artemisia rutifolia essential oil and extraction process and application thereof | NORTHWEST INST PLATEAU BIO CAS | 2012-08-29 | — | — | CN | disclosed |
| CN-101717692-A | Artemisia rutifolia essential oil and extraction process and application thereof | NORTHWEST INST OF PLATEAU BIOL | 2010-06-02 | — | — | CN | disclosed |
| EP-1767514-B1 | Process for the isomerisation of alkenylalkoxybenzenen | SYMRISE GMBH & CO KG (DE) | 2010-03-31 | — | — | EP | disclosed |
| CN-100577649-C | Electroluminescent device | CIBA SC HOLDING AG | 2010-01-06 | — | — | CN | disclosed |
| US-20090176856-A1 | MUSCARINIC RECEPTOR ANTAGONISTS | RANBAXY LABORATORIES LIMITED (IN) | 2009-07-09 | — | — | US | disclosed |
| US-20070073089-A1 | Process for the Isomerisation of Alkenyl Alkoxybenzenes | SYMRISE GMBH & CO. KG (DE) | 2007-03-29 | — | — | US | disclosed |
| EP-1767514-A1 | Process for the isomerisation of alkenylalkoxybenzenen | Symrise GmbH & Co. KG (DE) | 2007-03-28 | — | — | EP | disclosed |
| CN-1708485-A | Electroluminescent device | CIBA SC HOLDING AG (CH) | 2005-12-14 | — | — | CN | disclosed |
| US-6299785-B1 | Electrode formation process | JSR CORPORATION (JP) | 2001-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176856-A1 | MUSCARINIC RECEPTOR ANTAGONISTS | CHRM3, CHRM5, CHRM2 | CYP1A2 541/4885CYP1A1 733/4885CYP1B1 1043/4885 |
| US-20070073089-A1 | Process for the Isomerisation of Alkenyl Alkoxybenzenes | ADH1C, ADH1A, AKR7A2 | CYP1A2 20/4885CYP1A1 18/4885CYP1B1 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.